Δ2-Avermectin B1a is a degradation product formed by the reversible base-catalyzed isomerization of ivermectin B1a (Item No. 18768).1 It is less active than ivermectin against T. urticae (LC90s = 0.23 and 0.038 ppm, respectively).WARNING This product is not for human or veterinary use.